Results 111 to 120 of about 770 (146)
Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone for the Treatment of High-Risk Newly Diagnosed Multiple Myeloma. [PDF]
J Clin OncolLeypoldt LB, Tichy D, Besemer B, Hänel M, Raab MS, Mann C, Munder M, Reinhardt HC, Nogai A, Görner M, Ko YD, de Wit M, Salwender H, Scheid C, Graeven U, Peceny R, Staib P, Dieing A, Einsele H, Jauch A, Hundemer M, Zago M, Požek E, Benner A, Bokemeyer C, Goldschmidt H, Weisel KC. +26 moreeuropepmc +1 more sourceReal-world analysis of teclistamab in 123 RRMM patients from Germany. [PDF]
LeukemiaRiedhammer C, Bassermann F, Besemer B, Bewarder M, Brunner F, Carpinteiro A, Einsele H, Faltin J, Frenking J, Gezer D, Goldman-Mazur S, Hänel M, Hoegner M, Kortuem KM, Krönke J, Kull M, Leitner T, Mann C, Mecklenbrauck R, Merz M, Morgner A, Nogai A, Raab MS, Teipel R, Wäsch R, Rasche L. +25 moreeuropepmc +1 more sourceInhibition of high CXCR4 with motixafortide and absence of single-cell MRD predict outcome after AML consolidation.
BloodCeran E, Jaramillo Segura S, Merbach AK, Rohde C, Wass M, Schaffrath J, Durruthy-Durruthy R, Arribas-Layton M, Sciambi A, Rieger K, Nogai A, Hänel M, Herbst R, Stölzel F, Röllig C, Jost E, Schlenk RF, Lotze M, Noppeney R, Brandts C, Krug U, Götze KS, Buske S, Florschütz A, Schubert J, Opitz B, Eßeling E, von Witzendorff S, Subklewe M, Kaufmann M, Frickhofen N, Scholz CW, Schäfer-Eckart K, Kunzmann V, Schmidt-Hieber M, Sayer H, Rank A, Hemmati P, Schüler F, Scheller M, Kowoll S, Steighardt J, Edemir B, Ludwig-Kraus B, Müller LP, Edemir S, Vainstein-Haras A, Sorani E, Glicko-Kabir I, Kadosh S, Tavor S, Gromann C, Wienke A, Bauer M, Wickenhauser C, Baldus CD, Platzbecker U, Cerwenka A, Serve H, Bornhäuser M, Junghanß C, Müller-Tidow C. +61 moreeuropepmc +1 more sourceVenetoclax-Dexamethasone Versus Pomalidomide-Dexamethasone in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma: Primary Results of the Randomized, Phase III CANOVA Study. [PDF]
J Clin OncolPopat R, Beksac M, Dimopoulos MA, Gatt ME, Gay F, Jo JC, Kapoor P, Katodritou E, Kortüm KM, Ling S, Nagarajan C, Suzuki K, Qiu L, Onishi M, Ku G, Dail M, Mukherjee N, Ross JA, Badawi MA, Fusco MJ, Dobkowska E, Arriola E, Bueno OF, Bahlis NJ, Iida S, Moreau P, Valent J, Mateos MV. +27 moreeuropepmc +1 more sourceThe proteogenomic landscape of multiple myeloma reveals insights into disease biology and therapeutic opportunities. [PDF]
Nat CancerRamberger E, Sapozhnikova V, Ng YLD, Dolnik A, Ziehm M, Popp O, Sträng E, Kull M, Grünschläger F, Krüger J, Benary M, Müller S, Gao X, Murgai A, Haji M, Schmidt A, Lutz R, Nogai A, Braune J, Laue D, Langer C, Khandanpour C, Bassermann F, Döhner H, Engelhardt M, Straka C, Hundemer M, Beule D, Haas S, Keller U, Einsele H, Bullinger L, Knop S, Mertins P, Krönke J. +34 moreeuropepmc +1 more source
